| scholarly article | Q13442814 |
| P50 | author | Javier Conde-Vancells | Q83081486 |
| Alessia Omenetti | Q37829246 | ||
| P2093 | author name string | Liu Yang | |
| Wing-Kin Syn | |||
| Youngmi Jung | |||
| Anna Mae Diehl | |||
| Cynthia D Guy | |||
| Manal Abdelmalek | |||
| Jiangbo Wang | |||
| Rafal P Witek | |||
| Steve S Choi | |||
| Thiago A Pereira | |||
| Gamze F Karaca | |||
| Vanessa Teaberry | |||
| Caitlin M Fearing | |||
| P2860 | cites work | Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened | Q24682703 |
| Smad-dependent and Smad-independent pathways in TGF-beta family signalling | Q28208250 | ||
| Liver fibrosis | Q29547449 | ||
| Epithelial-mesenchymal transitions in development and pathologies | Q29614986 | ||
| An overview of epithelio-mesenchymal transformation | Q30014826 | ||
| Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease | Q30303621 | ||
| Functional Wnt signaling is increased in idiopathic pulmonary fibrosis | Q33334369 | ||
| Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions | Q33731663 | ||
| Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways | Q33988087 | ||
| Dose- and route-dependent teratogenicity, toxicity, and pharmacokinetic profiles of the hedgehog signaling antagonist cyclopamine in the mouse. | Q34082587 | ||
| Early role of Fsp1 in epithelial-mesenchymal transformation | Q34445512 | ||
| Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease | Q35792208 | ||
| Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells | Q35797586 | ||
| Identification and characterization of a fibroblast marker: FSP1 | Q36382596 | ||
| Distinct mechanisms of apoptosis-induced compensatory proliferation in proliferating and differentiating tissues in the Drosophila eye. | Q36514191 | ||
| Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans | Q36726189 | ||
| Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans | Q36890842 | ||
| Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins | Q36960032 | ||
| Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice | Q38297119 | ||
| Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease | Q38344957 | ||
| Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway | Q40028490 | ||
| Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro | Q40130232 | ||
| Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats | Q40204147 | ||
| Hedgehog signaling maintains resident hepatic progenitors throughout life | Q40345226 | ||
| Role for hedgehog signaling in hepatic stellate cell activation and viability | Q40371810 | ||
| Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis | Q40424064 | ||
| Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. | Q40560477 | ||
| Development and characterization of polarized primary cultures of rat intrahepatic bile duct epithelial cells | Q41254687 | ||
| Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells | Q41980364 | ||
| A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver | Q43722483 | ||
| Medulloblastoma growth inhibition by hedgehog pathway blockade | Q44119270 | ||
| BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury | Q44479221 | ||
| The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies | Q45209585 | ||
| Ductular reaction and its diagnostic significance. | Q52229994 | ||
| Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. | Q53540807 | ||
| Bile ductules and stromal cells express hedgehog ligands and/or hedgehog target genes in primary biliary cirrhosis. | Q53556864 | ||
| The hedgehog pathway regulates remodelling responses to biliary obstruction in rats. | Q54539811 | ||
| Bone Morphogenic Protein-7 Induces Mesenchymal to Epithelial Transition in Adult Renal Fibroblasts and Facilitates Regeneration of Injured Kidney | Q58214852 | ||
| The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes | Q59650980 | ||
| Hedgehog-mediated mesenchymal–epithelial interactions modulate hepatic response to bile duct ligation | Q61050018 | ||
| Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation | Q71832696 | ||
| Differentiation of oval cells into duct-like cells in preneoplastic liver of rats placed on a choline-deficient diet supplemented with ethionine | Q71988343 | ||
| The oval-shaped cell as a candidate for a liver stem cell in embryonic, neonatal and precancerous liver: identification based on morphology and immunohistochemical staining for albumin and pyruvate kinase isoenzyme expression | Q73230162 | ||
| Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis | Q73735584 | ||
| Nonalcoholic fatty liver disease | Q74119103 | ||
| Primary culture of cholangiocytes from normal mouse liver | Q77157531 | ||
| In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease | Q79788222 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| P304 | page(s) | 1478-1488.e8 | |
| P577 | publication date | 2009-07-03 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease | |
| P478 | volume | 137 |
| Q39340993 | A hedgehog survival pathway in 'undead' lipotoxic hepatocytes. |
| Q34060210 | Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. |
| Q33745654 | Alcohol activates the hedgehog pathway and induces related procarcinogenic processes in the alcohol-preferring rat model of hepatocarcinogenesis. |
| Q37865870 | Anti-fibrogenic strategies and the regression of fibrosis |
| Q37738637 | Antifibrotic therapies: will we ever get there? |
| Q42334109 | Can a fibrotic liver afford epithelial-mesenchymal transition? |
| Q27027703 | Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update |
| Q34450810 | Characterization of the early proliferative response of the rodent bladder to subtotal cystectomy: a unique model of mammalian organ regeneration |
| Q57107750 | Contribution of Resident Stem Cells to Liver and Biliary Tree Regeneration in Human Diseases |
| Q35754181 | Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression |
| Q26992106 | Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer |
| Q35062521 | Cyclopamine attenuates acute warm ischemia reperfusion injury in cholestatic rat liver: hope for marginal livers |
| Q42693950 | Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis |
| Q93148554 | Downregulation of miR-152 contributes to the progression of liver fibrosis via targeting Gli3 in vivo and in vitro |
| Q26748338 | Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases |
| Q38710580 | Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality? |
| Q35536589 | Enhanced Wnt/β-catenin and Notch signalling in the activated canine hepatic progenitor cell niche |
| Q38453116 | Epithelial Mesenchymal Transition: a double-edged sword |
| Q38533025 | Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations |
| Q28083351 | Epithelial-mesenchymal transition: An emerging target in tissue fibrosis |
| Q37440129 | Evidence for and against epithelial-to-mesenchymal transition in the liver |
| Q30539166 | Evolving therapies for liver fibrosis |
| Q33865082 | Fibrosis-dependent mechanisms of hepatocarcinogenesis |
| Q37450330 | GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment |
| Q39442387 | GLI1 inhibition promotes epithelial-to-mesenchymal transition in pancreatic cancer cells |
| Q36288278 | Galectin-3, histone deacetylases, and Hedgehog signaling: Possible convergent targets in schistosomiasis-induced liver fibrosis |
| Q57456594 | Gene is Crucial for Methionine-Choline-Deficient Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice |
| Q42451107 | Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice |
| Q42379051 | Growth factor- and cytokine-driven pathways governing liver stemness and differentiation |
| Q33771703 | Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis |
| Q36402141 | Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease |
| Q36799703 | Hedgehog pathway and pediatric nonalcoholic fatty liver disease |
| Q27322930 | Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer |
| Q54322921 | Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis. |
| Q36795740 | Hedgehog signaling in cholangiocytes |
| Q37811158 | Hedgehog signaling in the liver |
| Q40706711 | Hedgehog signaling influences gender-specific response of liver to radiation in mice |
| Q34060199 | Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice |
| Q36976060 | Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner |
| Q37965128 | Hedgehog signalling in gut development, physiology and cancer |
| Q47589566 | Hedgehog signalling in liver pathophysiology |
| Q36677171 | Hedgehog signalling regulates liver sinusoidal endothelial cell capillarisation |
| Q37777696 | Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites |
| Q84449591 | Hepatic progenitor cells: Another piece in the nonalcoholic fatty liver disease puzzle |
| Q36699261 | Hepatic regeneration and the epithelial to mesenchymal transition |
| Q35728873 | Hepatitis C virus infection: establishment of chronicity and liver disease progression |
| Q42376280 | Hesperetin alleviates renal interstitial fibrosis by inhibiting tubular epithelial-mesenchymal transition in vivo and in vitro |
| Q90330545 | Histological, Immunohistochemical, and Biochemical Study of Experimentally Induced Fatty Liver in Adult Male Albino Rat and the Possible Protective Role of Pomegranate |
| Q39690407 | Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes |
| Q34306736 | Histopathology of nonalcoholic fatty liver disease |
| Q45061974 | Human germline hedgehog pathway mutations predispose to fatty liver. |
| Q36773522 | Increased production of sonic hedgehog by ballooned hepatocytes |
| Q38134486 | Inhibition of Hedgehog signaling in the gastrointestinal tract: targeting the cancer microenvironment. |
| Q37201550 | Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. |
| Q49940586 | Involvement of epithelial-mesenchymal transition in liver fibrosis |
| Q49724255 | Lingguizhugan Decoction Protects against High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress and Activating Cholesterol Secretion. |
| Q92798647 | Lipometabolism and Glycometabolism in Liver Diseases |
| Q37599488 | Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling |
| Q38895164 | Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes |
| Q41819809 | Loss of cilia causes embryonic lung hypoplasia, liver fibrosis, and cholestasis in the talpid3 ciliopathy mutant. |
| Q36457220 | Macrophage-derived Hedgehog ligands promotes fibrogenic and angiogenic responses in human schistosomiasis mansoni |
| Q55450066 | MicroRNA-378 is involved in hedgehog-driven epithelial-to-mesenchymal transition in hepatocytes of regenerating liver. |
| Q26740198 | MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling |
| Q57807657 | Molecular pathways of nonalcoholic fatty liver disease development and progression |
| Q30375036 | Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. |
| Q27022840 | Myofibroblasts |
| Q33844463 | NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. |
| Q36626940 | NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease |
| Q89531776 | Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis |
| Q64257065 | New Insights into the Role of Epithelial⁻Mesenchymal Transition during Aging |
| Q34802344 | New concepts in liver regeneration |
| Q24563068 | Non-alcoholic fatty liver disease: what the clinician needs to know |
| Q36588292 | Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis. |
| Q34255535 | Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation |
| Q34511187 | Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. |
| Q33746198 | Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication |
| Q35805769 | Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice |
| Q61338068 | Osteopontin: A missing link between hedgehog signaling and fibrosis in nonalcoholic steatohepatitis |
| Q38108842 | Osteopontin: Versatile modulator of liver diseases |
| Q64987408 | Past, present and future perspectives in nonalcoholic fatty liver disease. |
| Q83094715 | Pathology of nonalcoholic fatty liver disease |
| Q26827117 | Pathophysiology guided treatment of nonalcoholic steatohepatitis |
| Q35770306 | Phenolic secoiridoids in extra virgin olive oil impede fibrogenic and oncogenic epithelial-to-mesenchymal transition: extra virgin olive oil as a source of novel antiaging phytochemicals. |
| Q42233793 | Possible role of sonic hedgehog and epithelial-mesenchymal transition in renal cell cancer progression. |
| Q28533455 | Potential role of Hedgehog pathway in liver response to radiation |
| Q34347580 | Principles of liver regeneration and growth homeostasis |
| Q26766727 | Promising Therapy Candidates for Liver Fibrosis |
| Q30365017 | Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. |
| Q35816355 | Reemergence of hedgehog mediates epithelial-mesenchymal crosstalk in pulmonary fibrosis |
| Q33797788 | Retracted: Up-Regulation of Sonic Hedgehog Contributes to TGF-β1-Induced Epithelial to Mesenchymal Transition in NSCLC Cells |
| Q26998093 | Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? |
| Q26765903 | Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial Phenotype |
| Q35086417 | Role of Fn14 in acute alcoholic steatohepatitis in mice |
| Q26743373 | Role of Hedgehog Signaling Pathway in NASH |
| Q58758006 | Role of canonical Hedgehog signaling pathway in liver |
| Q33907632 | Steatosis and steatohepatitis: complex disorders |
| Q26765898 | Stem/Progenitor Cell Niches Involved in Hepatic and Biliary Regeneration |
| Q36737131 | TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis |
| Q37975555 | Targeting the Hedgehog signaling pathway for cancer therapy |
| Q26801375 | The Impact of Hedgehog Signaling Pathway on DNA Repair Mechanisms in Human Cancer |
| Q47126762 | The Injury-Related Activation of Hedgehog Signaling Pathway Modulates the Repair-Associated Inflammation in Liver Fibrosis |
| Q52349162 | The hedgehog pathway in nonalcoholic fatty liver disease. |
| Q37807765 | The role of Hedgehog signaling in fibrogenic liver repair |
| Q24613730 | The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer |
| Q30613139 | The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice |
| Q38740036 | Transforming growth factor-β1 stimulates hedgehog signaling to promote epithelial-mesenchymal transition after kidney injury |
| Q37847181 | Treatment of non-alcoholic fatty liver disease with focus on emerging drugs |
| Q42370433 | Tumor necrosis factor-inducible gene 6 protein ameliorates chronic liver damage by promoting autophagy formation in mice. |
| Q89110155 | Underrated enemy - from nonalcoholic fatty liver disease to cancers of the gastrointestinal tract |
| Q35489968 | Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication. |
| Q35119509 | Update on fatty liver disease and steatohepatitis. |
| Q34307301 | Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma. |
| Q36437061 | Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model |
| Q36277100 | Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease |
Search more.